您当前所在的位置:首页 > 产品中心 > 产品信息
Testosterone_分子结构_CAS_58-22-0)
点击图片或这里关闭

Testosterone

产品号 DB00624 公司名称 DrugBank
CAS号 58-22-0 公司网站 http://www.ualberta.ca/
分子式 C19H28O2 电 话 (780) 492-3111
分子量 288.42442 传 真
纯 度 电子邮件 david.wishart@ualberta.ca
保 存 Chembase数据库ID: 506

产品价格信息

请登录

产品别名

标题
Testosterone
IUPAC标准名
(1S,2R,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one
IUPAC传统名
testosterone
商标名
Perandren
Malerone
Malogen, Aquaspension Injection
Testosteroid
Striant
Primotest
Androlin
Andropository 200
Cristerona T
Mertestate
Testandrone
Testolin
Testopropon
Testryl
Virilon IM
Virosterone
Andriol
Andro
Andro L.A. 200
Androgel
Android 5
Andronaq
Andronate 200
Neo-Hombreol F
Oreton
Oreton Methyl
Orquisteron
Sustanone
Sustason 250
Testamone 100
Testiculosterone
Testobase
Testogel
Testoviron T
Testred Cypionate 200
Virormone
Androsorb
Andro 100
Androderm
Android 10
Android 25
Andronate 100
Andropatch
Andrusol
Andryl 200
CDB 111C
Cristerone T
Delatest
Delatestryl
Depo-Testosterone Cypionate
Depotest
Everone 200
Geno-Cristaux Gremy
Homosteron
Homosterone
Malestrone
Malogen in Oil
Metandren
Methyltestosterone
Neotestis
Oreton F
Oreton-F
Percutacrine Androgenique
Primoteston
Relibra
Scheinpharm Testone-Cyp
Sustanon
Synandrol F
Teslen
Testim
Testoderm
Testoderm Tts
Testopel Pellets
Testoviron Schering
Testrin-P.A
Testro Aq
Testrone
Virilon
Beta Testosterone
Depo-Testosterone
Libigel
Neo-Testis
T-Cypionate
Testaqua
Testoject-50
Testoviron
Testred
别名
Testostosterone
Testosteron
Testosteronum [INN-Latin]
TES
Testosterone Hydrate
Testosterone Enanthate
Testosterone Cypionate
Trans-Testosterone
testosterone
Testosterona [INN-Spanish]
Dea No. 4000

产品登记号

PubChem SID 46505691
CAS号 58-22-0
PubChem CID 6013

产品性质

疏水性(logP) 3.6
溶解度 23.4 mg/L

产品详细信息

详细说明 (English)
Item Information
Drug Groups approved; investigational
Description Testosterone is a steroid sex hormone found in both men and women. In men, testosterone is produced primarily by the Leydig (interstitial) cells of the testes when stimulated by luteinizing hormone (LH). It functions to stimulate spermatogenesis, promote physical and functional maturation of spermatozoa, maintain accessory organs of the male reproductive tract, support development of secondary sexual characteristics, stimulate growth and metabolism throughout the body and influence brain development by stimulating sexual behaviors and sexual drive. In women, testosterone is produced by the ovaries (25%), adrenals (25%) and via peripheral conversion from androstenedione (50%). Testerone in women functions to maintain libido and general wellbeing. Testosterone exerts a negative feedback mechanism on pituitary release of LH and follicle-stimulating hormone (FSH). Testosterone may be further converted to dihydrotestosterone or estradiol depending on the tissue.
Indication To be used as hormone replacement or substitution of diminished or absent endogenous testosterone. Use in males: For management of congenital or acquired hypogonadism, hypogonadism associated with HIV infection, and male climacteric (andopause). Use in females: For palliative treatment of androgen-responsive, advanced, inoperable, metastatis (skeletal) carcinoma of the breast in women who are 1-5 years postmenopausal; testosterone esters may be used in combination with estrogens in the management of moderate to severe vasomotor symptoms associated with menopause in women who do not respond to adequately to estrogen therapy alone.
Pharmacology Testosterone is a steroid hormone from the androgen group. Testosterone is primarily secreted from the testes of males. In females, it is produced in the ovaries, adrenal glands and by conversion of adrostenedione in the periphery. It is the principal male sex hormone and an anabolic steroid. In both males and females, it plays key roles in health and well-being. Examples include enhanced libido, energy, immune function, and protection against osteoporosis. On average, the adult male body produces about twenty times the amount of testosterone than an adult female's body does.
Toxicity Side effects include amnesia, anxiety, discolored hair, dizziness, dry skin, hirsutism, hostility, impaired urination, paresthesia, penis disorder, peripheral edema, sweating, and vasodilation.
Affected Organisms
Humans and other mammals
Biotransformation Testosterone is metabolized to 17-keto steroids through two different pathways. The major active metabolites are estradiol and dihydrotestosterone (DHT).
Absorption Approximately 10% of the testosterone dose applied on the skin surface is absorbed into systemic circulation
Half Life 10-100 minutes
Protein Binding 40% of testosterone in plasma is bound to sex hormone-binding globulin and 2% remains unbound and the rest is bound to albumin and other proteins.
Elimination About 90% of a dose of testosterone given intramuscularly is excreted in the urine as glucuronic and sulfuric acid conjugates of testosterone and its metabolites; about 6% of a dose is excreted in the feces, mostly in the unconjugated form.
References
Freeman ER, Bloom DA, McGuire EJ: A brief history of testosterone. J Urol. 2001 Feb;165(2):371-3. [Pubmed]
Hoberman JM, Yesalis CE: The history of synthetic testosterone. Sci Am. 1995 Feb;272(2):76-81. [Pubmed]
Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility. Lancet. 1990 Oct 20;336(8721):955-9. [Pubmed]
External Links
Wikipedia
RxList
PDRhealth

参考文献

  • Freeman ER, Bloom DA, McGuire EJ: A brief history of testosterone. J Urol. 2001 Feb;165(2):371-3. Pubmed
  • Hoberman JM, Yesalis CE: The history of synthetic testosterone. Sci Am. 1995 Feb;272(2):76-81. Pubmed
  • Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility. Lancet. 1990 Oct 20;336(8721):955-9. Pubmed